Intracellular trafficking of nonviral vectors

Gene Therapy

Volumn 12, Issue 24, 2005, Pages 1734-1751

  Medina Kauwe, L K ^a,b   Xie, J ^c   Hamm Alvarez, S ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cytoskeleton; Nonviral; Trafficking; Vector

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTENNAPEDIA PROTEIN; ASIALOOROSOMUCOID; BAFILOMYCIN A1; BASIC FIBROBLAST GROWTH FACTOR; CHLOROQUINE; CLOSTRIDIUM DIFFICILE TOXIN B; COAT PROTEIN; COLCHICINE DERIVATIVE; CYTOCHALASIN B; DIPHTHERIA TOXIN; DNA; FOLIC ACID; GENE PRODUCT; INSULIN; LIGAND; LIPOFECTIN; LIPOPLEX; LIPOSOME; MELITTIN; NEU DIFFERENTIATION FACTOR; NOCODAZOLE; POLYLYSINE; SUPERPARAMAGNETIC IRON OXIDE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; UNINDEXED DRUG; VIRUS VECTOR; VPR PROTEIN; WORTMANNIN;

ARTICLE; CELL INTERACTION; CELL NUCLEUS; CELL TRANSPORT; EVOLUTION; GENE EXPRESSION SYSTEM; GENE TRANSFER; GENE VECTOR; HUMAN; IMMUNOGENICITY; MEDICAL RESEARCH; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PATHOGENICITY; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; CELL NUCLEUS; CYTOSOL; ENDOCYTOSIS; ENDOSOMES; FORECASTING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIGANDS; LIPOSOMES; MITOSIS; PROTEIN TRANSPORT;

CLOSTRIDIUM DIFFICILE;

EID: 28844460780     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302592     Document Type: Article

References (232)

1. Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
2. Duzgunes N et al. Cationic liposomes for gene delivery: Novel cationic lipids and enhancement by proteins and peptides. Curr Med Chem 2003; 10: 1213-1220.
3. Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
4. Howard KA, Alpar HO. The development of polyplex-based DNA vaccines. J Drug Targeting 2002; 10: 143-151.
5. Oupicky D, Ogris M, Seymour LW. Development of long-circulating polyelectrolyte complexes for systemic delivery of genes. J Drug Targeting 2002; 10: 93-98.
6. Tsai JT et al. Quantitative physical characterization of lipid-polycation-DNA lipopolyplexes. Biotechnol Appl Biochem 2002; 36: 13-20.
7. Yang J-P, Huang L. Novel supramolecular assemblies for gene delivery. In: Kabanov AV, Felgner PL, Seymour LW (eds). Self-Assembling Complexes for Gene Delivery. John Wiley & Sons: Chichester, 1998.
8. Manning GS. The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides. Quart Rev Biophys 1978; 11: 179-246.
9. Tang MX, Szoka Jr FC. Characterization of polycation complexes with DNA. In: Kabanov AV, Felgner PL, Seymour LW (eds). Self-Assembling Complexes for Gene Delivery. John Wiley & Sons: Chichester, 1998.
10. Vigneron JP et al. Guanidinium-cholesterol cationic lipids: Efficient vectors for the transfection of eukaryotic cells. Proc Natl Acad Sci USA 1996; 93: 9682-9686.
11. Felgner PL et al. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7417.
12. Wattiaux R, Laurent N, Wattiaux-De Coninck S, Jadot M. Endosomes, lysosomes: Their implication in gene transfer. Adv Drug Deliv Rev 2000; 41: 201-208.
13. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
14. Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 1996; 24: 596-601.
15. Fraley R, Subramani S, Berg P, Papahadjopoulos D. Introduction of liposome-encapsulated SV40 DNA into cells. J Biol Chem 1980; 255: 10431-10435.
16. Felgner PL. Progress in gene delivery research and development. In: Huang L, Hung MC, Wagner E (eds). Nonviral Vectors for Gene Therapy. Academic Press: San Diego, 1999, pp 25-38.
17. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system (erratum appears in J Biol Chem 1988 Jan 5; 263(1): 588). J Biol Chem 1987; 262: 4429-4432.
18. Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1988; 263: 14621-14624.
19. Wagner E et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. 1990; 87: 3410-3414.
20. Curiel DT. High-efficiency gene transfer mediated by adenovirus-polylysine-DNA complexes. Ann NY Acad Sci 1994; 716: 36-56; discussion 56-38.
21. Fominaya J, Uherek C, Wels W. A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor. Gene Therapy 1998; 5: 521-530.
22. Huckett B, Ariatti M, Hawtrey AO. Evidence for targeted gene transfer by receptor-mediated endocytosis. Stable expression following insulin-directed entry of NEO into HepG2 cells. Biochem Pharmacol 1990; 40: 253-263.
23. Rosenkranz AA et al. Receptor-mediated endocytosis and nuclear transport of a transfecting DNA construct. Exp Cell Res 1992; 199: 323-329.
24. Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481-8487.
25. Mislick KA, Baldeschwieler JD, Kayyem JF, Meade TJ. Transfection of folate-polylysine DNA complexes: Evidence for lysosomal delivery. Bioconjugate Chem 1995; 6: 512-515.
26. Gottschalk S, Cristiano RJ, Smith LC, Woo SL. Folate receptor mediated DNA delivery into tumor cells: Potosomal disruption results in enhanced gene expression. Gene Therapy 1994; 1: 185-191.
27. Sosnowski BA et al. Targeting DNA to cells with basic fibroblast growth factor (FGF2). J Biol Chem 1996; 271: 33647-33653.
28. Harbottle RP et al. An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery (see comment). Human Gene Ther 1998; 9: 1037-1047.
29. Hart SL et al. Gene delivery and expression mediated by an integrin-binding peptide (erratum appears in Gene Ther 1996 Nov; 3(11): 1032-1033). Gene Therapy 1995; 2: 552-554.
30. Harvie P et al. Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs. J Liposome Res 2003; 13: 231-247.
31. Medina-Kauwe LK, Maguire M, Kasahara N, Kedes L. Non-viral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. Gene Therapy 2001; 8: 1753-1761.
32. Buschle M et al. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3T cell receptor complex. Hum Gene Ther 1995; 6: 753-761.
33. Finke S et al. Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene. Gene Therapy 1998; 5: 31-39.
34. Ebert O et al. Lymphocyte apoptosis: Induction by gene transfer techniques. Gene Therapy 1997; 4: 296-302.
35. Kircheis R et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Therapy 1997; 4: 409-418.
36. Merwin JR et al. CD5-mediated specific delivery of DNA to T lymphocytes: compartmentalization augmented by adenovirus. J Immunol Methods 1995; 186: 257-266.
37. Chen J, Stickles RJ, Daichendt KA. Galactosylated histone-mediated gene transfer and expression. Hum Gene Ther 1994; 5: 429-435.
38. Cristiano RJ, Roth JA. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Therapy 1996; 3: 4-10.
39. Foster BJ, Kern JA. HER2-targeted gene transfer. Hum Gene Ther 1997; 8: 719-727.
40. Curiel DT, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. 1991; 88: 8850-8854.
41. Wagner E et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 1992; 89: 6099-6103.
42. Fominaya J, Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J Biol Chem 1996; 271: 10560-10568.
43. Medina-Kauwe LK, Kasahara N, Kedes L. 3PO, a novel non-viral gene delivery system using engineered Ad5 penton proteins. Gene Therapy 2001; 8: 795-803.
44. Hardingham TE, Fosang AJ. Proteoglycans: Many forms and many functions. FASEB J 1992; 6: 861-870.
45. Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA 1996; 93: 12349-12354.
46. Baeuerle PA, Huttner WB. Chlorate - a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun 1986; 141: 870-877.
47. Mounkes LC et al. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J Biol Chem 1998; 273: 26164-26170.
48. Simoes S et al. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Therapy 1999; 6: 1798-1807.
49. Menozzi FD et al. Enhanced bacterial virulence through exploitation of host glycosaminoglycans. Mol Microbiol 2002; 43: 1379-1386.
50. Bomsel M, Alfsen A. Entry of viruses through the epithelial barrier: pathogenic trickery. Nat Rev Mol Cell Biol 2003; 4: 57-68.
51. Rentsendorj A et al. The Ad5 fiber mediates non-viral gene transfer in the absence of the whole virus, utilizing a novel cell entry pathway. Gene Therapy 2004; advance online publication 14 October 2004; doi:10.1038/sj.gt.3302402.
52. Vives RR, Lortat-Jacob H, Chroboczek J, Fender P. Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron. Virology 2004; 321: 332-340.
53. Bergelson JM et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
54. 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
55. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 2000; 268: 382-390.
56. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev 1997; 77: 759-803.
57. Larkin JM, Donzell WC, Anderson RG. Potassium-dependent assembly of coated pits: New coated pits form as planar clathrin lattices. J Cell Biol 1986; 103: 2619-2627.
58. Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993; 123: 1107-1117.
59. Benmerah A et al. AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J Cell Biol 1998; 140: 1055-1062.
60. Benmerah A, Bayrou M, Cerf-Bensussan N, Dautry-Varsat A. Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci 1999; 112: 1303-1311.
61. Hinrichsen L et al. Effect of clathrin heavy chain- and alpha-adaptin-specific small inhibitory RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells. J Biol Chem 2003; 278: 45160-45170. Epub 2003 Sep 06.
62. Hinshaw JE, Schmid SL. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding [comment]. Nature 1995; 374: 190-192.
63. Schmid SL, McNiven MA, De Camilli P. Dynamin and its partners: A progress report. Curr Opin Cell Biol 1998; 10: 504-512.
64. Mousavi SA, Malerod L, Berg T, Kjeken R. Clathrin-dependent endocytosis. Biochem J 2004; 377: 1-16.
65. Rothman JE, Schmid SL. Enzymatic recycling of clathrin from coated vesicles. Cell 1986; 46: 5-9.
66. Van Dyke RW. Acidification of lysosomes and endosomes. Subcell Biochem 1996; 27: 331-360.
67. Presley JF et al. The End2 mutation in CHO cells slows the exit of transferrin receptors from the recycling compartment but bulk membrane recycling is unaffected. J Cell Biol 1993; 122: 1231-1241.
68. Gluck SL. The vacuolar H(+)-ATPases: Versatile proton pumps participating in constitutive and specialized functions of eukaryotic cells. Int Rev Cytol 1993; 137C: 105-137.
69. Yoshimori T et al. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 1991; 266: 17707-17712.
70. Bowman EJ, Siebers A, Altendorf K. Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 1988; 85: 7972-7976.
71. Wagner E. Application of membrane-active peptides for nonviral gene delivery. Adv Drug Deliv Rev 1999; 38: 279-289.
72. Phillips SC. Receptor-mediated DNA delivery approaches to human gene therapy. Biologicals 1995; 23: 13-16.
73. Sheff DR, Daro EA, Hull M, Mellman I. The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J Cell Biol 1999; 145: 123-139.
74. Widera A, Norouziyan F, Shen WC. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery. Adv Drug Deliv Rev 2003; 55: 1439-1466.
75. Mayor S, Presley JF, Maxfield FR. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J Cell Biol 1993; 121: 1257-1269.
76. Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: New insights and common mechanisms. Traffic 2003; 4: 724-738.
77. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84: 1341-1379.
78. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004; 377: 159-169.
79. Mundy DI et al. Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J Cell Sci 2002; 115: 4327-4339.
80. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001; 3: 473-483.
81. McIntosh DP, Tan XY, Oh P, Schnitzer JE. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: A pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci USA 2002; 99: 1996-2001.
82. Carver LA, Schnitzer JE. Caveolae: Mining little caves for new cancer targets. Nat Rev Cancer 2003; 3: 571-581.
83. Schnitzer JE. Caveolae: From basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 2001; 49: 265-280.
84. Grimmer S, van Deurs B, Sandvig K. Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J Cell Sci 2002; 115: 2953-2962.
85. Dangoria NS et al. Extracellular simian virus 40 induces an ERK/MAP kinase-independent signalling pathway that activates primary response genes and promotes virus entry. J Gen Virol 1996; 77: 2173-2182.
86. Dowrick P, Kenworthy P, McCann B, Warn R. Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor-treated cells. Eur J Cell Biol 1993; 61: 44-53.
87. Araki N, Johnson MT, Swanson JA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 1996; 135: 1249-1260.
88. West MA et al. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr Biol 2000; 10: 839-848.
89. Just I et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995; 375: 500-503.
90. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422: 37-44.
91. Meier O et al. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 2002; 158: 1119-1131.
92. Zuhorn IS, Kalicharan R, Hoekstra D. Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J Biol Chem 2002; 277: 18021-18028. Epub 2002 Mar 01.
93. Castanho MA, Prieto M, Jameson DM. The pentaene macrolide antibiotic filipin prefers more rigid DPPC bilayers: A fluorescence pressure dependence study. Biochim Biophys Acta 1999; 1419: 1-14.
94. Rodal SK et al. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 1999; 10: 961-974.
95. Shin JS, Abraham SN. Cell biology. Caveolae - not just craters in the cellular landscape. Science 2001; 293: 1447-1448.
96. Huth S et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004; 6: 923-936.
97. Tammi R et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 2001; 276: 35111-35122. Epub 2001 Jul 12.
98. Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994; 127: 1217-1232.
99. Goncalves C et al. Macropinocytosis of polyplexes and recycling of plasmid via the clathrin-dependent pathway impair the transfection efficiency of human hepatocarcinoma cells. Mol Ther 2004; 10: 373-385.
100. Colin M et al. Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Therapy 2000; 7: 139-152.
101. Heuser JE, Anderson RG. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 1989; 108: 389-400.
102. Li G et al. Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5. Proc Natl Acad Sci USA 1995; 92: 10207-10211.
103. Salisbury JL, Keller GA. Structural investigations on the role of microfilaments in ligand translocation. Methods Enzymol 1983; 98: 368-375.
104. Brown EJ. Phagocytosis. Bioessays 1995; 17: 109-117.
105. Kichler A et al. Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J Virol 2000; 74: 5424-5431.
106. Coeytaux E et al. The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem 2003; 278: 18110-18116. Epub 2003 Mar 14.
107. Fujimoto T, Kogo H, Nomura R, Une T. Isoforms of caveolin-1 and caveolar structure. J Cell Sci 2000; 113: 3509-3517.
108. Schwarze SR, Hruska KA, Dowdy SF. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol 2000; 10: 290-295.
109. Futaki S et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001; 276: 5836-5840.
110. Lundberg M, Wikstrom S, Johansson M. Cell surface adherence and endocytosis of protein transduction domains. Mol Ther: J Am Soc Gene Ther 2003; 8: 143-150.
111. Console S et al. Antennapedia and HIV transactivator of transcription (TAT) 'protein transduction domains' promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 2003; 278: 35109-35114.
112. Silhol M et al. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 2002; 269: 494-501.
113. Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001; 276: 3254-3261. Epub 2000 Oct 06.
114. Fuchs SM, Raines RT. Pathway for polyarginine entry into mammalian cells. Biochemistry 2004; 43: 2438-2444.
115. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004; 10: 310-315. Epub 2004 Feb 08.
116. Norbury CC et al. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 1995; 3: 783-791.
117. Rentsendorj A et al. The Ad5 fiber mediates nonviral gene transfer in the absence of the whole virus, utilizing a novel cell entry pathway. Gene Therapy 2005; 12: 225-237.
118. Eguchi A et al. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 2001; 276: 26204-26210. Epub 2001 May 09.
119. Fittipaldi A et al. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem 2003; 278: 34141-34149. Epub 2003 May 27.
120. Hyndman L et al. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J Control Release 2004; 99: 435-444.
121. Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: Characterization and mechanism of action. Biochim Biophys Acta 1994; 1189: 195-203.
122. Friend DS, Papahadjopoulos D, Debs RJ. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta 1996; 1278: 41-50.
123. Vendeville A et al. HIV-1 Tat enters T cells using coated pits before translocatiog from acidified endosomes and eliciting biological responses. Mol Biol Cell 2004; 15: 2347-2360. Epub 2004 Mar 2312.
124. Zatloukal K et al. Transferrinfection: A highly efficient way to express gene constructs in eukaryotic cells. Ann NY Acad Sci 1992; 660: 136-153.
125. Olsnes S, van Deurs B, Sandvig K. Protein toxins acting on intracellular targets: Cellular uptake and translocation to the cytosol. Med Microbiol Immunol 1993; 182: 51-61.
126. Zhan H et al. Interaction of the isolated transmembrane domain of diphtheria toxin with membranes. Biochemistry 1995; 34: 4856-4863.
127. Fisher KJ, Wilson JM. The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. Biochem J 1997; 321: 49-58.
128. Uherek C, Fominaya J, Wels W. A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery. J Biol Chem 1998; 273: 8835-8841.
129. Allende D, Simon SA, McIntosh TJ. Melittin-induced bilayer leakage depends on lipid material properties: Evidence for toroidal pores. Biophys J 2004; 13: 13.
130. Yang L et al. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 2001; 81: 1475-1485.
131. Ogris M, Carlisle RC, Bettinger T, Seymour LW. Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors. J Biol Chem 2001; 276: 47550-47555. Epub 2001 Oct 12.
132. Li W, Nicol F, Szoka Jr FC. GALA: A designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 2004; 56: 967-985.
133. Parente RA, Nir S, Szoka Jr FC. Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry 1990; 29: 8720-8728.
134. Nir S, Nicol F, Szoka Jr FC. Surface aggregation and membrane penetration by peptides: Relation to pore formation and fusion. Mol Membr Biol 1999; 16: 95-101.
135. Kakudo T et al. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: An artificial viral-like delivery system. Biochemistry 2004; 43: 5618-5628.
136. Haensler J, Szoka Jr FC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 1993; 4: 372-379.
137. Gottschalk S et al. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Therapy 1996; 3: 48-57.
138. Wyman TB et al. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 1997; 36: 3008-3017.
139. Legendre JY, Szoka Jr FC. Cyclic amphipathic peptide-DNA complexes mediate high-efficiency transfection of adherent mammalian cells. Proc Natl Acad Sci USA 1993; 90: 893-897.
140. Fattal E, Nir S, Parente RA, Szoka Jr FC. Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry 1994; 33: 6721-6731.
141. Kumar VV et al. Single histidine residue in head-group region is sufficient to impart remarkable gene transfection properties to cationic lipids: Evidence for histidine-mediated membrane fusion at acidic pH. Gene Therapy 2003; 10: 1206-1215.
142. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1995; 1235: 289-295.
143. Mok KW, Cullis PR. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys J 1997; 73: 2534-2545.
144. Koltover I, Salditt T, Radler JO, Safinya CR. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 1998; 281: 78-81.
145. Allen TM, Hong K, Papahadjopoulos D. Membrane contact, fusion, and hexagonal (HII) transitions in phosphatidylethanolamine liposomes. Biochemistry 1990; 29: 2976-2985.
146. Xu Y, Szoka Jr FC. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996; 35: 5616-5623.
147. Devaux PF. Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct 1992; 21: 417-439.
148. Barron LG, Szoka Jr FC. The perplexing delivery mechanism of lipoplexes. In: Huang L, Hung MC, Wagner E (eds). Nonviral Vectors for Gene Therapy. Academic Press: San Diego, 1999, pp 229-266.
149. Zelphati O, Szoka Jr FC. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci USA 1996; 93: 11493-11498.
150. Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 2003; 44: 233-242. Epub 2002 Dec 16.
151. Schneider E, Haest CW, Plasa G, Deuticke B. Bacterial cytotoxins, amphotericin B and local anesthetics enhance transbilayer mobility of phospholipids in erythrocyte membranes. Consequences for phospholipid asymmetry. Biochim Biophys Acta 1986; 855: 325-336.
152. Kichler A, Leborgne C, Coeytaux E, Danes O. Polyethylenimine-mediated gene delivery: A mechanistic study. J Gene Med 2001; 3: 135-144.
153. Sonawane ND, Szoka Jr FC, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003; 278: 44826-44831. Epub 2003 Aug 27.
154. Midoux P et al. Histidine containing peptides and polypeptides as nucleic acid vectors. Somat Cell Mol Genet 2002; 27: 27-47.
155. Midoux P, Monsigny M. Efficient gene transfer by histidylated polylysine/ pDNA complexes. Bioconjug Chem 1999; 10: 406-411.
156. Kichler A et al. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc Natl Acad Sci USA 2003; 100: 1564-1568. Epub 2003 Jan 31.
157. Vogt TC, Bechinger B. The interactions of histidine-containing amphipathic helical peptide antibiotics with lipid bilayers. The effects of charges and pH. J Biol Chem 1999; 274: 29115-29121.
158. Bechinger B. Towards membrane protein design: PH-sensitive topology of histidine-containing polypeptides. J Mol Biol 1996; 263: 768-775.
159. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981; 289: 366-373.
160. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. Structure of influenza haemagglutinin at the pH of membrane fusion. [see comment]. Nature 1994; 371: 37-43.
161. Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J Virol 1995; 69: 6643-6651.
162. Nishikawa M et al. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Therapy 2000; 7: 548-555.
163. Seth P, Willingham MC, Pastan I. Binding of adenovirus and its external proteins to Triton X-114. Dependence on pH. J Biol Chem 1985; 260: 14431-14434.
164. Wang K, Guan T, Cheresh DA, Nemerow GR. Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta5. J Virol 2000; 74: 2731-2739.
165. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 1994; 127: 257-264.
166. Fender P et al. Adenovirus dodecahedron, a new vector for human gene transfer [see comments]. Nat Biotechnol 1997; 15: 52-56.
167. Bal HP et al. Adenovirus type 7 penton purification of soluble pentamers from Escherichia coli and development of an integrin-dependent gene delivery system. Eur J Biochem 2000; 267: 6074-6081.
168. Prchla E et al. Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2. J Cell Biol 1995; 131: 111-123.
169. Rogers SL, Gelfand VI. Membrane trafficking, organelle transport, and the cytoskeleton. Curr Opin Cell Biol 2000; 12: 57-62.
170. Vallee RB, Sheetz MP. Targeting of motor proteins. Science 1996; 271: 1539-1544.
171. Ward BM. Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J Virol 2005; 79: 4755-4763.
172. Kelkar SA, Pfister KK, Crystal RG, Leopold PL. Cytoplasmic dynein mediates adenovirus binding to microtubules. J Virol 2004; 78: 10122-10132.
173. Douglas MW et al. Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J Biol Chem 2004; 279: 28522-28530. Epub 2004 Apr 26.
174. Suikkanen S et al. Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J Virol 2003; 77: 10270-10279.
175. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. Visualizing infection of individual influenza viruses. Proc Natl Acad Sci USA 2003; 100: 9280-9285. Epub 2003 Jul 25.
176. Petit C et al. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J Cell Sci 2003; 116: 3433-3442.
177. Hasegawa S, Hirashima N, Nakanishi M. Microtubule involvement in the intracellular dynamics for gene transfection mediated by cationic liposomes. Gene Therapy 2001; 8: 1669-1673.
178. Durrbach A, Louvard D, Coudrier E. Actin filaments facilitate two steps of endocytosis. J Cell Sci 1996; 109: 457-465.
179. Lindberg J, Fernandez MA, Ropp JD, Hamm-Alvarez SF. Nocodazole treatment of CV-1 cells enhances nuclear/perinuclear accumulation of lipid-DNA complexes and increases gene expression. Pharm Res 2001; 18: 246-249.
180. Wang L, MacDonald RC. Effects of microtubule-depolymerizing agents on the transfection of cultured vascular smooth muscle cells: Enhanced expression with free drug and especially with drug-gene lipoplexes. Mol Ther 2004; 9: 729-737.
181. Elkjaer ML et al. Effects of microtubule disruption on endocytosis, membrane recycling and polarized distribution of Aquaporin-1 and gp330 in proximal tubule cells. Eur J Cell Biol 1995; 67: 57-72.
182. Matteoni R, Kreis TE. Translocation and clustering of endosomes and lysosomes depends on microtubules. J Cell Biol 1987; 105: 1253-1265.
183. Thatte HS, Bridges KR, Golan DE. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells. J Cell Physiol 1994; 160: 345-357.
184. Liu SM, Magnusson KE, Sundqvist T. Microtubules are involved in transport of macromolecules by vesicles in cultured bovine aortic endothelial cells. J Cell Physiol 1993; 156: 311-316.
185. Rosette C, Karin M. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol 1995; 128: 1111-1119.
186. Krauzewicz N et al. Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids. Gene Therapy 2000; 7: 2122-2131.
187. Medina-Kauwe LK. Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Del Rev 2003; 55: 1485-1496.
188. Hamm-Alvarez SF, Xie J, Wang Y, Medina-Kauwe LK. Modulation of secretory functions in epithelia by adenovirus capsid proteins. J Control Release 2003; 93: 129-140.
189. Meier O, Greber UF. Adenovirus endocytosis. J Gene Med 2004; 6: S152-S163.
190. Wang Y et al. Adenoviral capsid modulates secretory compartment organization and function in acinar epithelial cells from rabbit lacrimal gland. Gene Therapy 2004; 11: 970-981.
191. Cervantes-Acosta G, Lodge R, Lemay G, Cohen EA. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/ polarization signal on viral accessory protein functions. J Hum Virol 2001; 4: 249-259.
192. Lechardeur D et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Therapy 1999; 6: 482-497.
193. Pollard H et al. Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J Gene Med 2001; 3: 153-164.
194. Torriglia A, Chaudun E, Courtois Y, Counis MF. On the use of Zn2+ to discriminate endonucleases activated during apoptosis. Biochimie 1997; 79: 435-438.
195. Lukacs GL et al. Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem 2000; 275: 1625-1629.
196. Leonetti JP et al. Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci USA 1991; 88: 2702-2706.
197. Zelphati O, Szoka Jr FC. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm Res 1996; 13: 1367-1372.
198. Pante N, Aebi U. Molecular dissection of the nuclear pore complex. Crit Rev Biochem Mol Biol 1996; 31: 153-199.
199. Stoffler D, Fahrenkrog B, Aebi U. The nuclear pore complex: From molecular architecture to functional dynamics. Curr Opin Cell Biol 1999; 11: 391-401.
200. Imamoto N. Diversity in nucleocytoplasmic transport pathways. Cell Struct Funct 2000; 25: 207-216.
201. Conti E, Izaurralde E. Nucleocytoplasmic transport enters the atomic age. Curr Opin Cell Biol 2001; 13: 310-319.
202. Clever J, Yamada M, Kasamatsu H. Import of simian virus 40 virions through nuclear pore complexes. Proc Natl Acad Sci USA 1991; 88: 7333-7337.
203. Sodeik B, Ebersold MW, Helenius A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J Cell Biol 1997; 136: 1007-1021.
204. Pante N, Aebi U. Sequential binding of import ligands to distinct nucleopore regions during their nuclear import. Science 1996; 273: 1729-1732.
205. Dabauvalle MC, Schulz B, Scheer U, Peters R. Inhibition of nuclear accumulation of karyophilic proteins in living cells by microinjection of the lectin wheat germ agglutinin. Exp Cell Res 1988; 174: 291-296.
206. Greber UF et al. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J 1997; 16: 5998-6007.
207. Finlay DR, Newmeyer DD, Price TM, Forbes DJ. Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores. J Cell Biol 1987; 104: 189-200.
208. Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 1991; 65: 232-244.
209. Pollard VW et al. A novel receptor-mediated nuclear protein import pathway. Cell 1996; 86: 985-994.
210. Dean DA. Import of plasmid DNA into the nucleus is sequence specific. Exp Cell Res 1997; 230: 293-302.
211. Holmes AR et al. Intracellular compartmentalization of DNA fragments in cultured airway epithelial cells mediated by cationic lipids. Pharm Res 1999; 16: 1020-1025.
212. Gao X, Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 1996; 35: 1027-1036.
213. Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Therapy 1997; 4: 961-968.
214. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989; 243: 375-378.
215. Fritz JD, Herweijer H, Zhang G, Wolff JA. Gene transfer into mammalian cells using histone-condensed plasmid DNA. Hum Gene Ther 1996; 7: 1395-1404.
216. Breeuwer M, Goldfarb DS. Facilitated nuclear transport of histone H1 and other small nucleophilic proteins. Cell 1990; 60: 999-1008.
217. Kurz M, Doenecke D, Albig W. Nuclear transport of H1 histones meets the criteria of a nuclear localization signal-mediated process. J Cell Biochem 1997; 64: 573-578.
218. Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear location. Cell 1984; 39: 499-509.
219. Collas P, Husebye H, Alestrom P. The nuclear localization sequence of the SV40T antigen promotes transgene uptake and expression in zebrafish embryo nuclei. Transgenic Res 1996; 5: 451-458.
220. Collas P, Alestrom P. Nuclear localization signal of SV40T antigen directs import of plasmid DNA into sea urchin male pronuclei in vitro. Mol Reprod Dev 1996; 45: 431-438.
221. Carlisle RC et al. Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors. Mol Ther 2001; 4: 473-483.
222. Wienhues U et al. A novel method for transfection and expression of reconstituted DNA-protein complexes in eukaryotic cells. DNA 1987; 6: 81-89.
223. Fischer N et al. Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin alpha2. J Biol Chem 1997; 272: 3999-4005.
224. Kapoor P, Frappier L. EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes. J Virol 2003; 77: 6946-6956.
225. Lee CG, Vieira WD, Pastan I, Gottesman MM. An episomally maintained MDR1 gene for gene therapy. Hum Gene Ther 2001; 12: 945-953.
226. Cassell GD, Weitzman MD. Characterization of a nuclear localization signal in the C-terminus of the adeno-associated virus Rep68/78 proteins. Virology 2004; 327: 206-214.
227. Brunner S et al. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Therapy 2000; 7: 401-407.
228. Brunner S et al. Overcoming the nuclear barrier: Cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol Ther 2002; 5: 80-86.
229. Dowty ME et al. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc Natl Acad Sci USA 1995; 92: 4572-4576.
230. Ludtke JJ, Sebestyen MG, Wolff JA. The effect of cell division on the cellular dynamics of microinjected DNA and dextran. Mol Ther 2002; 5: 579-588.
231. Remy JS et al. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses. 1995; 92: 1744-1748.
232. Pollard H et al. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem 1998; 273: 7507-7511.